title: Factors predicting 10-year survival after heart transplantation.
abstract: BACKGROUND
  We sought to identify factors predictive of long-term (>10-year) survival in heart transplant (HTx) recipients.
  
  
  METHODS
  Four hundred fifteen adult patients underwent HTx at our institution between August 1982 and May 1997. The 158 patients who survived >10 years (Group A) and the 116 patients who died between 2 and 6 years (Group B) of HTx were compared in terms of gender, gender mismatch, ethnicity, age, height, weight, United Network for Organ Sharing status, type of induction therapy (OKT3 or anti-thymocyte globulin), infections (bacterial, viral, fungal and protozoal), cytomegalovirus (CMV) status, CMV mismatch, diabetes mellitus, hypertension and incidence of rejection episodes and transplant coronary artery disease within 2 years of HTx.
  
  
  RESULTS
  Group A (135 men, 23 women; mean age 48 +/- 11 years) had significantly fewer post-HTx rejection episodes and viral, bacterial, fungal and total infections than did Group B (95 men, 21 women; mean age 49 +/- 12 years). Group A also had a significantly lower mean donor age, a lower incidence of pre-HTx diabetes, and a lower mean cholesterol level 1 year after HTx. In a multivariate analysis, fewer bacterial infections and rejection episodes after HTx, the absence of pre-HTx diabetes, and lower donor age were associated with longer survival.
  
  
  CONCLUSIONS
  Pre-HTx diabetes, donor age and incidences of infection and rejection within 2 years of HTx predict long-term (>10-year) survival. Better control of infection and rejection during the first 2 years after HTx may improve survival.
authors.affiliation: Department of Cardiopulmonary Transplantation, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77225, USA. bradovancevic@heart.thi.tmc.edu
authors.forename: Branislav
authors.initials: B
authors.lastname: Radovancevic
authors.forename: Cuneyt
authors.initials: C
authors.lastname: Konuralp
authors.forename: Bojan
authors.initials: B
authors.lastname: Vrtovec
authors.forename: Rajko
authors.initials: R
authors.lastname: Radovancevic
authors.forename: Cynthia D
authors.initials: CD
authors.lastname: Thomas
authors.forename: Munir
authors.initials: M
authors.lastname: Zaqqa
authors.forename: William K
authors.initials: WK
authors.lastname: Vaughn
authors.forename: O H
authors.initials: OH
authors.lastname: Frazier
mesh_terms: D000367:Age Factors; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000209:etiology / Q000401:mortality*; D006331:Heart Diseases / Q000601:surgery; D016027:Heart Transplantation; D006801:Humans; D015994:Incidence; D007239:Infections / Q000209:etiology / Q000401:mortality; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000401:mortality*; D011237:Predictive Value of Tests; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis; D013995:Time; D016896:Treatment Outcome